CSF3, colony stimulating factor 3, 1440

N. diseases: 687; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 Biomarker disease LHGDN Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. 17572226 2007
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 Therapeutic disease CTD_human Adverse events of MVAC chemotherapy in patients with advanced urothelial cancer of the bladder. 17515069 2007
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 AlteredExpression disease LHGDN To examine the association of granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor (G-CSFR) expression with increased beta1-integrin expression and determine the ability of autocrine G-CSFR signaling to promote bladder cancer cell adhesion by way of beta1-integrin. beta1-integrin is expressed at higher levels in more invasive bladder carcinoma cells and participates in the process of tissue invasion. 14751388 2004
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 Biomarker disease BEFREE To examine the association of granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor (G-CSFR) expression with increased beta1-integrin expression and determine the ability of autocrine G-CSFR signaling to promote bladder cancer cell adhesion by way of beta1-integrin. beta1-integrin is expressed at higher levels in more invasive bladder carcinoma cells and participates in the process of tissue invasion. 14751388 2004
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 Biomarker disease BEFREE In the present manuscript, we identify the factors constitutively produced by a human bladder cancer cell line (KU-19-19) that was found to produce beta human chorionic gonadotrophin (beta-hCG), granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin 1alpha (IL-1alpha), interleukin 6 (IL-6) and interleukin 8 (IL-8). 9231915 1997
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.330 Therapeutic disease CTD_human Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. 7525883 1994